Back to GILD
Crossmark Global Holdings, Inc. → GILD
Crossmark Global Holdings, Inc. GILD Position History
Gilead Sciences, Inc. • Healthcare
Quarters held
5
Latest value
$59.3M
Q3 2026
Peak value
$73.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $58.6M |
| Q4 2025 | $67.7M |
| Q1 2026 | $73.2M |
| Q2 2026 | $68.4M |
| Q3 2026 | $59.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $59.3M | 397.6K | — | — |
| Q2 2026 | $68.4M | 541.3K | — | — |
| Q1 2026 | $73.2M | 525.0K | — | — |
| Q4 2025 | $67.7M | 551.9K | — | — |
| Q3 2025 | $58.6M | 528.2K | — | — |
Other funds holding GILD
$13.3B
$12.5B
$12.5B
$11.9B
$8.3B
$7.7B
$7.7B
$7.4B